Impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care

被引:40
作者
Ballard, David J. [1 ]
Ogola, Gerald [1 ]
Fleming, Neil S. [1 ]
Stauffer, Brett D. [1 ]
Leonard, Bradley M. [2 ]
Khetan, Rainer [3 ]
Yancy, Clyde W. [4 ]
机构
[1] Baylor Hlth Care Syst, Inst Hlth Care Res & Improvement, Dallas, TX 75206 USA
[2] Heart Hosp Baylor Plano, Plano, TX USA
[3] Baylor Univ, Med Ctr, Dallas, TX USA
[4] Baylor Heart & Vasc Inst, Dallas, TX USA
关键词
quality improvement; quality indicators; mortality; readmissions; cardiovascular diseases; hospital care; INITIATE LIFESAVING TREATMENT; OF-CARE; US HOSPITALS; ORGANIZED PROGRAM; MANAGEMENT; RISK;
D O I
10.1093/intqhc/mzq051
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To determine the impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care. Observational study. Eight acute care hospitals and two specialty heart hospitals. All adults (> 18 years) discharged from one of the included hospitals between December 2007 and March 2009 with a diagnosis of heart failure, who had not undergone heart transplant, did not have a left ventricular assistive device, and with a length of stay of 120 or less days. A standardized heart failure order set was developed internally, with content driven by the prevailing American College of Cardiology/American Heart Association clinical practice guidelines, and deployed systemwide via an intranet physician portal. Publicly reported process of care measures, in-patient mortality, 30-day mortality, 30-day readmission, length of stay, and direct cost of care were compared for heart failure patients treated with and without the order set. Order set used reached 73.1% in March 2009. After propensity score adjustment, order set use was associated with significantly increased core measures compliance [odds ratio (95% confidence interval) = 1.51(1.08; 2.12)] and reduced in-patient mortality [odds ratio (95% confidence interval) = 0.49(0.28; 0.88)]. Reductions in 30-day mortality and readmission approached significance. Direct cost for initial admissions alone and in combination with readmissions were significantly lower with order set use. Implementing an evidence-based standardized order set may help improve outcomes, reduce costs of care and increase adherence to evidence-based processes of care.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 36 条
[1]  
Ahmed A, 2002, SOUTH MED J, V95, P703
[2]  
Antman EM, 2009, JAMA-J AM MED ASSOC, V302, P143, DOI 10.1001/jama.2009.912
[3]  
ANTMAN EM, 2009, JAMA-J AM MED ASSOC, V302, P145
[4]  
Ballard DJ., 2008, Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 2: Culture and Redesign)
[5]  
*BRIGH WOM HOSP, HEART FAIL QUAL MEAS
[6]   Implementing a Standardized Order Set for Community-Acquired Pneumonia: Impact on Mortality and Cost [J].
Fleming, Neil S. ;
Ogola, Gerald ;
Ballard, David J. .
JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2009, 35 (08) :414-+
[7]   Adherence to heart failure quality-of-care indicators in US hospitals - Analysis of the ADHERE Registry [J].
Fonarow, GC ;
Yancy, CW ;
Heywood, JT .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (13) :1469-1477
[8]   Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): Rationale and design [J].
Fonarow, GC ;
Abraham, WT ;
Albert, NM ;
Gattis, WA ;
Gheorghiade, M ;
Greenberg, B ;
O'Connor, CM ;
Yancy, CW ;
Young, J .
AMERICAN HEART JOURNAL, 2004, 148 (01) :43-51
[9]   Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure - Results of the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF) [J].
Fonarow, Gregg C. ;
Abraham, William T. ;
Albert, Nancy M. ;
Stough, Wendy Gattis ;
Gheorghiade, Mihai ;
Greenberg, Barry H. ;
O'Connor, Christopher M. ;
Pieper, Karen ;
Sun, Jie Lena ;
Yancy, Clyde W. ;
Young, James B. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (14) :1493-1502
[10]  
Fonarow Gregg C, 2002, Rev Cardiovasc Med, V3 Suppl 3, pS2